The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers. The trials are the first test of a new self-amplifying RNA technology which has the potential to revolutionise vaccine development and enable scientists to respond more quickly to emerging diseases.
First Volunteers Receive Imperial COVID-19 Vaccine
Video Jun 23, 2020 | Taken from Imperial College London
Recommended Videos
Urinalysis has long been a staple of physical exams to detect and manage a number of diseases and disorders, but not cancer. What if it were that easy, though, and cancer was detected in its very earliest stages when the disease responds more favorably to treatment and improved outcomes are more likely?
WATCH NOWLike what you just watched? You can find similar content on the communities below.
Drug Discovery Genomics Research Proteomics & Metabolomics Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE